Research ArticleCLINICAL INVESTIGATIONS
Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography
Till A. Heusner, Sherko Kuemmel, Lale Umutlu, Angela Koeninger, Lutz S. Freudenberg, Elke A.M. Hauth, Klaus R. Kimmig, Michael Forsting, Andreas Bockisch and Gerald Antoch
Journal of Nuclear Medicine August 2008, 49 (8) 1215-1222; DOI: https://doi.org/10.2967/jnumed.108.052050
Till A. Heusner
Sherko Kuemmel
Lale Umutlu
Angela Koeninger
Lutz S. Freudenberg
Elke A.M. Hauth
Klaus R. Kimmig
Michael Forsting
Andreas Bockisch
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography
Till A. Heusner, Sherko Kuemmel, Lale Umutlu, Angela Koeninger, Lutz S. Freudenberg, Elke A.M. Hauth, Klaus R. Kimmig, Michael Forsting, Andreas Bockisch, Gerald Antoch
Journal of Nuclear Medicine Aug 2008, 49 (8) 1215-1222; DOI: 10.2967/jnumed.108.052050
Breast Cancer Staging in a Single Session: Whole-Body PET/CT Mammography
Till A. Heusner, Sherko Kuemmel, Lale Umutlu, Angela Koeninger, Lutz S. Freudenberg, Elke A.M. Hauth, Klaus R. Kimmig, Michael Forsting, Andreas Bockisch, Gerald Antoch
Journal of Nuclear Medicine Aug 2008, 49 (8) 1215-1222; DOI: 10.2967/jnumed.108.052050
Related Articles
Cited By...
- 18F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging
- Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation
- Defining the Role of PET-CT in Staging Early Breast Cancer
- The Yield of 18F-FDG PET/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study
- FDG-PET/CT Compared with Conventional Imaging in the Detection of Distant Metastases of Primary Breast Cancer
- Initial Staging Impact of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Locally Advanced Breast Cancer
- Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results
- Prevention of Brown Adipose Tissue Activation in 18F-FDG PET/CT of Breast Cancer Patients Receiving Neoadjuvant Systemic Therapy